OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bloodstream Infection Due to a VIM-Metallo-β-Lactamase-Producing Klebsiella pneumoniae Treated with Cefiderocol in a Preterm Newborn
Caterina Monari, Ferdinando Spagnuolo, Mariantonietta Pisaturo, et al.
Infectious Diseases and Therapy (2022) Vol. 12, Iss. 2, pp. 727-734
Open Access | Times Cited: 13

Showing 13 citing articles:

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
Keith S. Kaye, Thierry Naas, Jason M. Pogue, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 3, pp. 777-806
Open Access | Times Cited: 35

Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it’s even arrived?
Chiara Russo, Alessio Mesini, Marcello Mariani, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 4, pp. 624-631
Open Access | Times Cited: 5

Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review
Francesco Venuti, Lorenza Romani, Maia De Luca, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1798-1798
Open Access | Times Cited: 12

New Antimicrobials for the Treatment of Neonatal Sepsis Caused by Multi-Drug-Resistant Bacteria: A Systematic Review
Chiara Poggi, Carlo Dani
Antibiotics (2023) Vol. 12, Iss. 6, pp. 956-956
Open Access | Times Cited: 10

Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
Angeliki Kontou, Maria Kourti, Εlias Iosifidis, et al.
Antibiotics (2023) Vol. 12, Iss. 6, pp. 1072-1072
Open Access | Times Cited: 9

Use of Cefiderocol in the Management of Children With Infection or Colonization With Multi-drug Resistant Gram-negative Bacteria: A Retrospective, Single-center Case Series
Hanna Schmid, Li‐An K. Brown, Bairavi Indrakumar, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 8, pp. 772-776
Closed Access | Times Cited: 2

Successful Use of Cefiderocol to Treat a Multidrug-resistant Stenotrophomonas maltophilia Ventilator-associated Pneumonia in an Extremely Preterm Neonate
Archana Koirala, Bharath Krishnappa, Caroline Banh, et al.
The Pediatric Infectious Disease Journal (2023) Vol. 42, Iss. 11, pp. 1012-1016
Closed Access | Times Cited: 6

The Use of Cefiderocol as Salvage Therapy in an Infant Receiving ECMO and Continuous Renal Replacement Therapy
Stefania Mercadante, Costanza Tripiciano, Lorenza Romani, et al.
Antibiotics (2023) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 4

Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis
Elisa Funiciello, Jacopo Mula, F Mignone, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 11, pp. 2776-2778
Closed Access | Times Cited: 2

Exploring the World of ß-Lactamase Inhibitors
Aditya Walia, Rajat Sharma, Nidhi Rani, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 92-118
Closed Access

Meropenem

Reactions Weekly (2023) Vol. 1947, Iss. 1, pp. 256-256
Closed Access

Page 1

Scroll to top